179 related articles for article (PubMed ID: 3460995)
21. Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues.
Satomura Y; Sawabu N; Takemori Y; Ohta H; Watanabe H; Okai T; Watanabe K; Matsuno H; Konishi F
Pancreas; 1991 Jul; 6(4):448-58. PubMed ID: 1678888
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical localization of CA 125 antigen in formalin-fixed paraffin sections of ovarian tumors with the use of Pronase.
Shishi J; Ghazizadeh M; Oguro T; Aihara K; Araki T
Am J Clin Pathol; 1986 May; 85(5):595-8. PubMed ID: 3518399
[TBL] [Abstract][Full Text] [Related]
23. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
[TBL] [Abstract][Full Text] [Related]
24. A study of the NB/7OK and CA 125 monoclonal antibody radioimmunoassays for measuring serum antigen levels in ovarian cancer patients.
Knauf S; Anderson DJ; Knapp RC; Bast RC
Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):911-3. PubMed ID: 2411137
[TBL] [Abstract][Full Text] [Related]
25. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
26. [An immunohistochemical study of various breast tissues using CA15-3 (MAb 115D8 and MAb DF3)].
Sekine H
Gan No Rinsho; 1987 Jul; 33(8):913-9. PubMed ID: 2441086
[TBL] [Abstract][Full Text] [Related]
27. CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis.
Del Favero G; Fabris C; Plebani M; Panucci A; Piccoli A; Perobelli L; Pedrazzoli S; Baccaglini U; Burlina A; Naccarato R
Cancer; 1986 Apr; 57(8):1576-9. PubMed ID: 3456255
[TBL] [Abstract][Full Text] [Related]
28. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Bhan AK
Int J Cancer; 1983 Nov; 32(5):547-54. PubMed ID: 6358053
[TBL] [Abstract][Full Text] [Related]
29. Concentration and localization of carbohydrate antigen 19-9 in tissues of pancreatic cancer.
Nishida K; Miyagawa H; Yoshikawa T; Kondo M
Oncology; 1988; 45(3):166-71. PubMed ID: 3163417
[TBL] [Abstract][Full Text] [Related]
30. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
[TBL] [Abstract][Full Text] [Related]
31. Expression of blood group-related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein.
Ichihara T; Sakamoto J; Nakao A; Furukawa K; Watanabe T; Suzuki N; Horisawa M; Nagura H; Lloyd KO; Takagi H
Cancer; 1993 Jan; 71(1):71-81. PubMed ID: 8416729
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72).
Klug TL; Sattler MA; Colcher D; Schlom J
Int J Cancer; 1986 Nov; 38(5):661-9. PubMed ID: 2429934
[TBL] [Abstract][Full Text] [Related]
33. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4].
Ohuchi N; Takahashi K; Matoba N; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
[TBL] [Abstract][Full Text] [Related]
35. Values of CA 19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor.
Tatsuta M; Yamamura H; Iishi H; Ichii M; Noguchi S; Yamamoto R; Okuda S
Cancer; 1985 Dec; 56(11):2669-73. PubMed ID: 3863691
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of CA 19-9 radioimmunoassay].
Toya D; Takemori Y; Kidani H; Yoneshima M; Hattori N; Sawabu N
Gan To Kagaku Ryoho; 1984 Mar; 11(3):509-14. PubMed ID: 6584087
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: preparation and use in a radioimmunoassay for measuring NB/70K in serum.
Knauf S; Kalwas J; Helmkamp BF; Harwell LW; Beecham J; Lord EM
Cancer Immunol Immunother; 1986; 21(3):217-25. PubMed ID: 2421899
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
39. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic oncofetal antigen and carbohydrate antigen 19-9 in sera of patients with cancer of the pancreas.
Shahangian S; Fritsche HA; Hughes JI; Gelder FB
Clin Chem; 1989 Mar; 35(3):405-8. PubMed ID: 2537687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
